FEATURES CLINICAL SYMPTOMS WAYS AND CORRECTION GONARTHROSIS AT REDUCED BONE MINERAL DENSITY
Authors: Shuba N.M. Tarasenko T.N. №55 (1) 2014 / Review: 11
Hyperurecemia — multimorbidity in rheumatology
Author:Shuba N.M. №52 (2) 2013 / Review: 13
Monitoring adverse events of low-dose glucocorticoid therapy: EULAR recommendations for clinical trials and daily practice
Authors: Goes der van M.C. Jacobs J.W.G. Boers M. Andrews T.... №51 (1) 2013 / Review: 10
NEW GOAL OF OSTEOPOROSIS TARGETED THERAPY — THE RANKL INHIBITOR DENOSUMAB
Author:Golovach I.Yu. №51 (1) 2013 / Review: 12
ACHIEVEMENTS TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №50 (4) 2012 / Review: 9
CYTOKINE MARKERS OF JUVENILE IDIOPATHIC ARTHRITIS ACTIVITY
Authors: Boyko Ya.Y. Chernyshov V.P. №48 (2) 2012 / Review: 10
SMOKING AND DEVELOPMENT OF RHEUMATOIS ARTHRITIS: PATHOGENETIC PUZZLES COMPLETION
Authors: Kovalenko V.M. Golovach I.Yu. Bortkevych O.P. №48 (2) 2012 / Review: 10
New aspects of the osteoarthritis pathogenesis and ways of correction
Authors: Shuba N.M. Voronova T.D. Tarasenko T.N. Krylova А.S. №47 (1) 2012 / Review: 8
Vitamin D deficient in male with peripheral arterial disease
Authors: Povoroznyuk V.V. Nishkumay O.I. Stroilo V.A. Stroilo N.G. №47 (1) 2012 / Review: 13
THE ADVANTAGE OF ALFACALCIDOL OVER VITAMIN D IN THE TREATMENT OF OSTEOPOROSIS
Authors: Shiraishi A. Higashi S. Ohkawa H. Kubodera N.... №43 (1) 2011г. / Review: 14